Bio Usawa Appoints Professor Prashant Yadav As Director And Chair Of New Global Access And Health Equity Advisory Board

Bio Usawa Inc., a biotechnology company focused on developing and delivering high-quality, affordable medicines, announced the appointment of Professor Prashant Yadav as Director and Chair of its newly established Global Access and Health Equity Advisory Board. This appointment reflects Bio Usawa’s strong commitment to integrating health equity and sustainable access into the core of its business strategy.

In his dual role, Professor Yadav will provide strategic oversight and guidance to help Bio Usawa achieve its mission on a global scale. As Chair, he will lead the Advisory Board in designing and implementing innovative access models, fostering partnerships to strengthen health systems, and ensuring that equity is embedded across all aspects of the company’s operations, from research and development to medicine delivery.

Dr. Menghis Bairu, CEO and President of Bio Usawa, stated that Professor Yadav brings unparalleled vision, practical expertise, and a deep commitment to equitable global healthcare. He noted that Professor Yadav has been an invaluable contributor to the company since its inception and that his appointment reinforces Bio Usawa’s dedication to measuring success not just by business milestones but by the positive impact on lives worldwide.

Professor Yadav is a globally recognized researcher, educator, and policy advisor in healthcare delivery. As a Senior Fellow at the Council on Foreign Relations, his work has influenced policy and discussion worldwide. His analyses have appeared in major publications including the Financial Times, The New York Times, The Economist, and Nature, and he frequently provides expert commentary for networks such as BBC, CNN, and NPR.

His career spans academia and hands-on impact in global health. He has held faculty and lecturer roles at INSEAD, MIT, the University of Michigan, and Harvard Medical School. He has also served as Strategy Leader for Supply Chains at the Bill & Melinda Gates Foundation and as Vice President of Healthcare Research at the William Davidson Institute, University of Michigan.

Professor Yadav expressed enthusiasm for joining Bio Usawa, highlighting the company’s mission-driven approach and its alignment of commercial goals with social impact. He emphasized the opportunity to translate innovative biotech solutions into equitable health outcomes and to build access pathways that ensure no community is left behind.

Bio Usawa, guided by the principle of “Usawa” (Swahili for equity or fairness), believes that business growth and social impact are interconnected. The creation of the Global Access and Health Equity Advisory Board under Professor Yadav’s leadership institutionalizes this principle, making equity a central part of the company’s strategic decisions.